$KITE Kite Pharma, Inc. Insider Trading Week 50/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. in week 50/2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | M | 6.89 | 9,000 | 62,010 | 103,000 | |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 65.27 | 491 | 32,048 | 6,342 | 6.8 K to 6.3 K (-7.19 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 64.58 | 3,488 | 225,255 | 6,833 | 10.3 K to 6.8 K (-33.80 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 63.59 | 2,285 | 145,303 | 10,321 | 12.6 K to 10.3 K (-18.13 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 62.64 | 2,736 | 171,383 | 12,606 | 15.3 K to 12.6 K (-17.83 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Buy | M | 6.89 | 9,000 | 62,010 | 15,342 | 6.3 K to 15.3 K (+141.91 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 645 | 10,965 | 33,233 | |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 5,500 | 3,850 | 96,625 | |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 64.97 | 1,145 | 74,391 | 2,198 | 3.3 K to 2.2 K (-34.25 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 64.27 | 2,400 | 154,248 | 3,343 | 5.7 K to 3.3 K (-41.79 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 62.76 | 2,600 | 163,176 | 5,743 | 8.3 K to 5.7 K (-31.16 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 645 | 10,965 | 8,343 | 7.7 K to 8.3 K (+8.38 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 5,500 | 3,850 | 7,698 | 2.2 K to 7.7 K (+250.23 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 123,464 | |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 65.38 | 432 | 28,244 | 2,941 | 3.4 K to 2.9 K (-12.81 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 64.64 | 3,352 | 216,673 | 3,373 | 6.7 K to 3.4 K (-49.84 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 63.73 | 2,410 | 153,589 | 6,725 | 9.1 K to 6.7 K (-26.38 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 62.70 | 3,373 | 211,487 | 9,135 | 12.5 K to 9.1 K (-26.97 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 12,508 | 2.9 K to 12.5 K (+325.30 %) |